|
Fallopian Tube Cancer Clinical Trials Data presented on Clinical Trials Search is not designed to be a substitute for qualified healthcare advice, visits or professional assistance with a genuine physician. We are not docs. Always consult your dr. on Fallopian Tube Cancer conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Fallopian Tube Cancer Clinical research trials and Fallopian Tube Cancer medical trials occur in a lot of of places throughout the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the effectivity of new does drugs. The propose of the studies / undertakings is to solve particular human medical questions. Clinical trials are a popular way for doctors, government agencies, and private sector corporations to locate remedies for all varieties of circumstances, like Fallopian Tube Cancer. Fallopian Tube Cancer Clinical Trials and other clinical trials allow volunteers to acquire healthcare treatment alternatives before they are available to the general public. Many times the participants acquire professional assistance for free of charge, and occasionally they are compensated for their time. Occasionally there is a cost for a Fallopian Tube Cancer clinical trial. Participants oftentimes receive the finest healthcare available for their Fallopian Tube Cancer condition. Hazards are a reality, nonetheless, and could include extra or frequent dr. trips, medical risks (perhaps life-endangering), and/or the treatment being ineffectual. Trials are federally regulated with stern guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > Clinical Trials by Conditions > "F" Clinical Trial Conditions > Fallopian Tube Cancer Clinical Trials
Fallopian Tube Cancer Clinical Trials
A clinical efficacy study of an oral tyrosine kinase inhibitor of VEGFR-2 to treat recurrent or persistent small-volume epithelial ovarian cancer, primary peritoneal serous cancer, or fallopian tube cancer
Condition: pfizer_clinical_trials.html
Pfizer
Adjuvant Intraperitoneal Carboplatin With Paclitaxel in Treating Patients Who Had Initial Debulking Surgery for Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
Condition: gynecologic_oncology_group_clinical_trials.html
Gynecologic Oncology Group
Bicalutamide and Goserelin in Treating Patients With Cancer of the Ovary, Fallopian Tube, or Peritoneum
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)
Bortezomib and Carboplatin in Treating Patients With Recurrent or Progressive Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
Condition: memorial_sloankettering_cancer_center_clinical_trials.html
Memorial Sloan-Kettering Cancer Center
Carboplatin and Paclitaxel With or Without Gemcitabine in Treating Patients With Ovarian Epithelial or Fallopian Tube Cancer
Condition: ago_ovarian_cancer_study_group_clinical_trials.html
AGO Ovarian Cancer Study Group
Cetuximab, Paclitaxel, and Carboplatin in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer
Condition: memorial_sloankettering_cancer_center_clinical_trials.html
Memorial Sloan-Kettering Cancer Center
Chemotherapy Plus Surgery in Treating Patients With Stage III or Stage IV Ovarian, Peritoneal, or Fallopian Tube Cancer
Condition: eortc_gynecological_cancer_cooperative_group_clinical_trials.html
EORTC Gynecological Cancer Cooperative Group
Cisplatin Plus Irinotecan in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)
Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Persistent Epithelial Ovarian Cancer, Fallopian Tube, or Primary Peritoneal Cancer
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)
Combination Chemotherapy and Surgery in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
Condition: southwest_oncology_group_clinical_trials.html
Southwest Oncology Group
Combination Chemotherapy Consisting of Gemcitabine And Topotecan in Treating Patients With Refractory or Recurrent Ovarian or Fallopian Tube Cancer
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)
Combination Chemotherapy in Treating Patients With Endometrial Cancer, Fallopian Tube Cancer, or Sarcoma of the Female Reproductive Tract
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)
Combination Chemotherapy in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer
Condition: ago_ovarian_cancer_study_group_clinical_trials.html
AGO Ovarian Cancer Study Group
Combination Chemotherapy in Treating Patients With Previously Untreated, Newly Diagnosed Epithelial Tumors
Condition: beth_israel_deaconess_medical_center_clinical_trials.html
Beth Israel Deaconess Medical Center
Combination Chemotherapy in Treating Patients With Untreated Ovarian, Peritoneal, or Fallopian Tube Cancer
Condition: gynecologic_oncology_group_clinical_trials.html
Gynecologic Oncology Group
Combination Chemotherapy in Treating Women With Stage III Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Condition: southwest_oncology_group_clinical_trials.html
Southwest Oncology Group
Combination Chemotherapy Plus Erlotinib in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
Condition: kaplan_cancer_center_clinical_trials.html
Kaplan Cancer Center
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)
Combination Chemotherapy With or Without Whole-Body Hyperthermia in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer
Condition: ludwig_maximillian_universitaet_womens_hospital_clinical_trials.html
Ludwig Maximillian Universitaet Women's Hospital
Combination Chemotherapy, Bone Marrow Transplantation, and Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial Cancer
Condition: johns_hopkins_oncology_center_clinical_trials.html
Johns Hopkins Oncology Center
Comparison of Combination Chemotherapy Regimens in Treating Newly Diagnosed Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
Condition: national_cancer_institute_of_canada_clinical_trials.html
National Cancer Institute of Canada
CT-2103 in Treating Patients With Recurrent Ovarian Epithelial or Fallopian Tube Cancer or Primary Peritoneal Cancer
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)
Docetaxel Plus Carboplatin in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Condition: herbert_irving_comprehensive_cancer_center_clinical_trials.html
Herbert Irving Comprehensive Cancer Center
Early Chemotherapy Based on CA 125 Level Alone Compared With Delayed Chemotherapy in Treating Patients With Recurrent Ovarian Epithelial , Fallopian Tube, or Primary Peritoneal Cancer
Condition: medical_research_council_clinical_trials.html
Medical Research Council
Erlotinib and Carboplatin in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Condition: national_cancer_institute_of_canada_clinical_trials.html
National Cancer Institute of Canada
Imatinib Mesylate in Treating Patients With Refractory or Relapsed Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer, or Ovarian Low Malignant Potential Tumor
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)
Irinotecan in Treating Patients With Refractory Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
Condition: southwest_oncology_group_clinical_trials.html
Southwest Oncology Group
Irofulven in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal Cancer
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)
Liposomal Doxorubicin and Carboplatin in Treating Patients With Gynecologic Cancer
Condition: ago_ovarian_cancer_study_group_clinical_trials.html
AGO Ovarian Cancer Study Group
Lurtotecan Liposome in Treating Patients With Advanced or Recurrent Ovarian Epithelial Cancer
Condition: national_cancer_institute_of_canada_clinical_trials.html
National Cancer Institute of Canada
Monoclonal Antibody Therapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer
Condition: jonsson_comprehensive_cancer_center_clinical_trials.html
Jonsson Comprehensive Cancer Center
Monoclonal Antibody Vaccine Therapy in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer
Condition: memorial_sloankettering_cancer_center_clinical_trials.html
Memorial Sloan-Kettering Cancer Center
Oxaliplatin and Topotecan in Treating Patients With Previously Treated Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
Condition: kaplan_cancer_center_clinical_trials.html
Kaplan Cancer Center
Paclitaxel and Carboplatin With or Without Epirubicin in Treating Patients With Stage IIB, Stage III, or Stage IV Invasive Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer
Condition: nordic_society_for_gynaecologic_oncology_clinical_trials.html
Nordic Society for Gynaecologic Oncology
Paclitaxel in Treating Patients With Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)
Paclitaxel Plus Carboplatin With or Without Topotecan in Treating Patients With Stage IIB, Stage III, or Stage IV Ovarian Epithelial Cancer
Condition: ago_ovarian_cancer_study_group_clinical_trials.html
AGO Ovarian Cancer Study Group
Polyglutamate Paclitaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer
Condition: gynecologic_oncology_group_clinical_trials.html
Gynecologic Oncology Group
PS-341 Plus Carboplatin in Platinum and Taxane Resistant Recurrent Ovarian Cancer, Primary Peritoneal Cancer, and Fallopian Tube Cancer
Condition: md_anderson_cancer_center_clinical_trials.html
M.D. Anderson Cancer Center
Radiation Therapy to the Abdomen Plus Docetaxel in Treating Patients With Recurrent or Persistent Advanced Ovarian, Peritoneal, or Fallopian Tube Cancer
Condition: gynecologic_oncology_group_clinical_trials.html
Gynecologic Oncology Group
Tamoxifen Compared With Thalidomide in Treating Women With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Condition: gynecologic_oncology_group_clinical_trials.html
Gynecologic Oncology Group
Taurolidine in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)
Timing of Surgery and Chemotherapy in Treating Patients With Newly Diagnosed Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer
Condition: royal_college_of_obstetricians_and_gynecologists_clinical_trials.html
Royal College of Obstetricians and Gynecologists
TLK286 Compared With Either Liposomal Doxorubicin or Topotecan as Third-Line Therapy in Treating Patients With Platinum-Refractory or Platinum-Resistant Metastatic Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
Condition: memorial_sloankettering_cancer_center_clinical_trials.html
Memorial Sloan-Kettering Cancer Center
TLK286 in Treating Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)
Topotecan in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
Condition: beth_israel_deaconess_medical_center_clinical_trials.html
Beth Israel Deaconess Medical Center
Topotecan Plus Etoposide in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer
Condition: national_cancer_institute_nci_clinical_trials.html
National Cancer Institute (NCI)
UCN-01 and Topotecan in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer
Condition: princess_margaret_hospital_clinical_trials.html
Princess Margaret Hospital
UCN-01 and Topotecan in Treating Patients With Recurrent, Persistent, or Progressive Advanced Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
Condition: princess_margaret_hospital_clinical_trials.html
Princess Margaret Hospital
Vaccine Therapy in Treating Patients With Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
Condition: memorial_sloankettering_cancer_center_clinical_trials.html
Memorial Sloan-Kettering Cancer Center
Weekly Infusions of Paclitaxel in Treating Women With Stage III or Stage IV Ovarian Cancer Refractory to Paclitaxel and Platinum
Condition: theradex_clinical_trials.html
Theradex
Fallopian Tube Cancer Clinical Trials
|
|
|
|
|
|
|
|
